Danaher Corporation (NYSE: DHR) announced today that it expects first quarter 2018 adjusted diluted net earnings per share to be above the high-end of the Company's previously communicated guidance range.

Thomas P. Joyce, Jr., President and Chief Executive Officer, stated, "We have seen a strong start to 2018 from both a core revenue and margin perspective and based on our results through February, we now expect first quarter 2018 adjusted EPS to be above the high-end of our previously communicated guidance range. Better than expected results in our Life Sciences and Diagnostics platforms – specifically at Cepheid – are the main drivers for this performance as we continue to see positive momentum in these businesses."

The Company will hold its quarterly earnings conference call for the first quarter 2018 on Thursday, April 19, 2018 at 8:00 a.m. ET.

ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System. For more information, please visit www.danaher.com.